Features of bacterial DNA taxonomy in blood of patients with various metabolic phenotypes of obesity
https://doi.org/10.20538/1682-0363-2023-2-61-67
Abstract
Aim. To study the blood microbiome taxonomy in patients with metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO).
Materials and methods. The study included healthy donors without obesity (n = 116) and obese patients who were divided into subgroups with MHO (n = 36) and MUHO (n = 53). Bacterial DNA isolated from blood samples was subject to metagenomic sequencing of the v3–v4 variable region in the 16S rRNA gene. We compared the frequency of isolating certain taxa from the samples and the proportion of these taxa in the total pool of bacterial DNA in the blood.
Results. MUHO patients showed an increase in Lachnospiraceae, Ruminococcaceae, and Prevotellaceae, which are the main taxa in gut microbiota. This may indicate greater intestinal permeability in such patients. Obese patients, regardless of the metabolic phenotype of obesity, more often had Rhodobacteraceae, Streptomycetaceae, Leuconostocaceae, and Burkholderiaceae DNA in their blood. Nocardioidaceae, Flavobacteriaceae, Hyphomicrobiaceae, and Gaiellaceae DNA were more frequently present in the blood microbiome of patients with MHO, whereas MUHO patients more often had S24-7, Nocardiaceae, and Helicobacteraceae DNA in their blood. Many members of these families inhabit soil and water, which may indicate increased skin barrier permeability in obese patients. Additionally, a higher number of Helicobacteraceae-positive blood samples in the MUHO patient group may indicate increased translocation from the stomach.
Conclusion. Obesity is accompanied by changes in the taxonomic composition of the blood microbiome. Moreover, the nature of the changes depends on the metabolic phenotype of obesity and the permeability of external barriers.
Keywords
About the Authors
I. M. KolesnikovaRussian Federation
1, Ostrovityanova Str., Moscow, 117997
M. S. Karbyshev
Russian Federation
1, Ostrovityanova Str., Moscow, 117997
A. M. Gaponov
Russian Federation
32, Nakhimovsky Av., Moscow, 117218;
25/2, Petrovka Str., Moscow, 107031
D. R. Khusnutdinova
Russian Federation
18, Kremlyovskaya Str., Kazan, 420008
T. V. Grigoryeva
Russian Federation
18, Kremlyovskaya Str., Kazan, 420008
D. R. Kamaldinova
Russian Federation
18, Kremlyovskaya Str., Kazan, 420008
O. V. Borisenko
Russian Federation
1, Ostrovityanova Str., Moscow, 117997
V. V. Makarov
Russian Federation
10/1, Pogodinskaya Str., Moscow, 119121
S. M. Yudin
Russian Federation
10/1, Pogodinskaya Str., Moscow, 119121
S. A. Roumiantsev
Russian Federation
1, Ostrovityanova Str., Moscow, 117997;
32, Nakhimovsky Av., Moscow, 117218
A. V. Shestopalov
Russian Federation
1, Ostrovityanova Str., Moscow, 117997;
32, Nakhimovsky Av., Moscow, 117218;
1, Samory Mashela Str., Moscow, 117997
References
1. Nikkari S., McLaughlin I.J., Bi W., Dodge D.E., Relman D.A. Does blood of healthy subjects contain bacterial ribosomal DNA? J. Clin. Microbiol. 2001;39(5):1956–1959. DOI: 10.1128/JCM.39.5.1956-1959.2001.
2. Федоров Н.А., Елов А.А., Жибурт Е.Б., Суханов Ю.С., Круглов A.Н., Стоногин А.В. и др. Частота обнаружения бактериальной ДНК в цельной крови доноров. Доклады Академии наук. 2005;402(6):841–843. DOI: 10.1007/s10630-005-0085-y.
3. Castillo D.J., Rifkin R.F., Cowan D.A., Potgieter M. The healthy human blood microbiome: Fact or fiction? Front. Cell. Infect. Microbiol. 2019;9:1–12. DOI: 10.3389/fcimb.2019.00148.
4. Гапонов А.М., Волкова Н.И., Ганенко Л.А., Набока Ю.Л., Маркелова М.И., Синягина М.Н. и др. Особенности микробиома толстой кишки у пациентов с ожирением при его различных фенотипах (оригинальная статья). Журнал микробиологии, эпидемиологии и иммунобиологии. 2021;98(2):144–155. DOI: 10.36233/0372-9311-66.
5. Котрова А.Д., Шишкин А.Н., Воропаева Л.С., Лавренова Н.С., Слепых Л.А., Лукашенко М.В. и др. Гендерная оценка микробиома кишечника у больных с ожирением. Клиническая гастроэнтерология. 2021;(10):91–99. DOI: 10.31146/1682-8658-ecg-194-10-91-99.
6. Шестопалов А.В., Колесникова И.М., Гапонов А.М., Григорьева Т.В., Хуснутдинова Д.Р. Камальдинова Д.Р. и др. Влияние метаболического типа ожирения на микробиом крови. Вопросы биологической, медицинской и фармацевтической химии. 2022;25(2):35–41. DOI: 10.29296/25877313-2022-02-06.
7. Massier L., Blüher M., Kovacs P., Chakaroun R.M. Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases. Front. Endocrinol. (Lausanne). 2021;12(March):1–18. DOI: 10.3389/fendo.2021.616506.
8. Iacobini C., Pugliese G., Blasetti Fantauzzi C., Federici M., Menini S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. Elsevier Inc. 2019;92:51–60. DOI: 10.1016/j.metabol.2018.11.009.
9. Phillips C.M. Metabolically healthy obesity: Definitions, determinants and clinical implications. Rev. Endocr. Metab. Disord. 2013;14(3):219–227. DOI: 10.1007/s11154-013-9252-x.
10. Hirt P.A., Castillo D.E., Yosipovitch G., Keri J.E. Skin changes in the obese patient. J. Am. Acad. Dermatol. 2019;81(5): 1037–1057. DOI: 10.1016/j.jaad.2018.12.070.
Review
For citations:
Kolesnikova I.M., Karbyshev M.S., Gaponov A.M., Khusnutdinova D.R., Grigoryeva T.V., Kamaldinova D.R., Borisenko O.V., Makarov V.V., Yudin S.M., Roumiantsev S.A., Shestopalov A.V. Features of bacterial DNA taxonomy in blood of patients with various metabolic phenotypes of obesity. Bulletin of Siberian Medicine. 2023;22(2):61-67. https://doi.org/10.20538/1682-0363-2023-2-61-67